DHVI-IVQAC Biorepository Receives Accreditation from College of American Pathologists
The Accreditation Committee of the College of American Pathologists (CAP) has awarded accreditation to the Duke Human Vaccine Institute-Immunology Virology Quality Assessment Center’s (DHVI-IVQAC) biorepository based on the results of a recent on-site inspection as part of the CAP’s Accreditation Programs.
Duke Human Vaccine Team Awarded Up to $9 million To Study Fungal Fever
The Duke Human Vaccine Institute’s Vaccine and Treatment Evaluation Unit has received an initial award of approximately $5 million from the National Institute of Allergy and Infectious Diseases (NIAID) to support further research on Valley Fever Pneumonia.
DHVI-IVQAC Biorepository Receives Accreditation from College of American Pathologists
The Accreditation Committee of the College of American Pathologists (CAP) has awarded accreditation to the Duke Human Vaccine Institute-Immunology Virology Quality Assessment Center’s (DHVI-IVQAC) biorepository based on the results of a recent on-site inspection as part of the CAP’s Accreditation Programs.